In vitro, expression of ARID1A in ARID1A-deficient ovarian cancer cell lines reduced cellular proliferation, the percentage of cells in the S phase, and the growth of tumour xenografts [13]. The gene discussed is ARID1A; the disease is ovarian carcinoma.